Controlling Protein Fate to Treat Disease
controlling
protein fate
to treat
disease
protein fate
to treat
disease
Nurix Therapeutics discovers drugs that harness the body’s natural process to control protein levels.
Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases. Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents.